These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 30867310)
1. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release. Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310 [TBL] [Abstract][Full Text] [Related]
2. β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release. Tervo HM; Homann S; Ambiel I; Fritz JV; Fackler OT; Keppler OT Retrovirology; 2011 Feb; 8():9. PubMed ID: 21310048 [TBL] [Abstract][Full Text] [Related]
3. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release. Jafari M; Guatelli J; Lewinski MK J Virol; 2014 May; 88(9):5062-78. PubMed ID: 24574397 [TBL] [Abstract][Full Text] [Related]
4. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. Iwabu Y; Fujita H; Kinomoto M; Kaneko K; Ishizaka Y; Tanaka Y; Sata T; Tokunaga K J Biol Chem; 2009 Dec; 284(50):35060-72. PubMed ID: 19837671 [TBL] [Abstract][Full Text] [Related]
6. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages. Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316 [TBL] [Abstract][Full Text] [Related]
10. Vpu of a Simian Immunodeficiency Virus Isolated from Greater Spot-Nosed Monkey Antagonizes Human BST-2 via Two AxxxxxxxW Motifs. Yao W; Yoshida T; Hashimoto S; Takeuchi H; Strebel K; Yamaoka S J Virol; 2020 Jan; 94(2):. PubMed ID: 31666374 [TBL] [Abstract][Full Text] [Related]
11. Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly. Lewinski MK; Jafari M; Zhang H; Opella SJ; Guatelli J J Biol Chem; 2015 Apr; 290(17):10919-33. PubMed ID: 25759385 [TBL] [Abstract][Full Text] [Related]
12. βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin. Song YE; Cyburt D; Lucas TM; Gregory DA; Lyddon TD; Johnson MC Viruses; 2018 Oct; 10(10):. PubMed ID: 30347660 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691 [TBL] [Abstract][Full Text] [Related]
14. A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. Kueck T; Neil SJ PLoS Pathog; 2012; 8(3):e1002609. PubMed ID: 22479182 [TBL] [Abstract][Full Text] [Related]
15. Vpu binds directly to tetherin and displaces it from nascent virions. McNatt MW; Zang T; Bieniasz PD PLoS Pathog; 2013; 9(4):e1003299. PubMed ID: 23633949 [TBL] [Abstract][Full Text] [Related]
16. The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation. Janvier K; Pelchen-Matthews A; Renaud JB; Caillet M; Marsh M; Berlioz-Torrent C PLoS Pathog; 2011 Feb; 7(2):e1001265. PubMed ID: 21304933 [TBL] [Abstract][Full Text] [Related]
17. Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression. Dotson D; Woodruff EA; Villalta F; Dong X J Biol Chem; 2016 Feb; 291(8):4236-46. PubMed ID: 26742839 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface. Dubé M; Paquay C; Roy BB; Bego MG; Mercier J; Cohen EA Traffic; 2011 Dec; 12(12):1714-29. PubMed ID: 21902775 [TBL] [Abstract][Full Text] [Related]
19. Tethered virions are intermediates in the assembly and release of HIV-1 particles. Karetnikov A; Suomalainen M Virology; 2010 Nov; 407(2):289-95. PubMed ID: 20850859 [TBL] [Abstract][Full Text] [Related]
20. Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain. Gustin JK; Douglas JL; Bai Y; Moses AV J Biol Chem; 2012 Apr; 287(18):14837-50. PubMed ID: 22383521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]